![Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,t…](https://static.cymitquimica.com/products/3D/img/JMB71436.png "Cliccare per ingrandire")
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate
CAS: 934714-36-0
Rif. 3D-JMB71436
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate is a prodrug of strontium that is hydrolyzed by esomeprazole and omeprazole to release the active form. Strontium has been shown to be effective in treatment of bowel disease. Strontium inhibits the production of prostaglandins and leukotrienes, leading to decreased inflammation in the gastrointestinal tract. It also has a therapeutic effect on reflux disease. Strontium can cause drug interactions with other drugs metabolized by cytochrome P450 enzymes (e.g., esomeprazole) or that inhibit gastric acid secretion (e.g., omeprazole).
Proprietà chimiche
Richiesta tecnica su: 3D-JMB71436 Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
